Enhance your nephrology practice with CME and tools focused on kidney medicine.
Vous prescrivez uniquement des antihistaminiques pour traiter les patients atteints de Pa-MRC ? Il est temps de revoir votre approche !
Antoine Lanot, MD, PhD
Gil Yosipovitch, MD
Advancing Patient-Centered, Guideline-Driven Management of Hyperkalemia in Adults With CKD and Associated Comorbidities
June 04, 2026
Glasgow
Translating Evidence Into Practice: Patient-Centered, Guideline-Driven Care in ANCA-Associated Vasculitis
Reframing IgAN Care: Patient-Centered Strategies to Curb Proteinuria and Preserve Kidney Function
June 05, 2026
Case-Based Approach: Managing Hyperkalemia in Patients With CKD and Heart Failure
Ellie Kelepouris, MD, FACP, FAHA
Nihar R. Desai, MD, MPH
CKD-aP or Something Else? Decoding the Diagnosis
James Burton, DM, FRCP
Emilio Sanchez, MD, PhD
CKD-aP Treatment Tool Kit
Leonie Kraft, MD
Elevating CKD-aP Care: New Frontier
Lucio Manenti, MD, PhD
Targeting CKD-aP at the Source: Key Mechanisms and Treatments
Steven Fishbane, MD
Maurizio Gallieni, MD
Quantifying CKD-aP: Tools for Better Care
The Patient-Clinician Connection in Managing CKD-aP
Kappa-Opioid Settings: Real-World Evidence Insights
Potassium Binders: Safety Comes First!
Javed Butler, MD, MPH, MBA
Oral Potassium Binders: A Novel Approach to Curb Hyperkalemia in CKD and HF
Patrick Rossignol, MD, PhD
Implementing Potassium Binders: Practical Dosing and Long-Term Follow Up
Guidelines Update: RAASi/MRA Therapy in CKD and HF Management
Navigating KDIGO Practice Guideline Recommendations to Maximize Proteinuria Reduction in Patients With IgAN
Chee Kay Cheung, MBChB, PhD, FRCP
Claudia Seikrit, MD
Stuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
Decoding Itch in CKD: From CKD-aP Suspicion to Solution
Is CKD-aP Hiding in Your Dialysis Center?
Future Directions in Managing Hyperkalemia in CKD and HF
Optimizing RAASi/MRA Therapy in Patients with Heart Failure, CKD, and Hyperkalemia: A Microlearning Curriculum Approach
Javed Butler, MD
The Critical Interplay: CKD, HF, and HyperkaleAmia
Case-Based Application: Optimizing RAASi/MRA Therapy with Potassium Binders
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Kidney Academy… but how about a more personalized experience?
Press cancel to remain on Global Kidney Academy. Press the link below or the continue button to keep going.